Skip to content

Apricitabine strong in phase 2 study, 24-week data released

One in four HIV patients feel stigmatised by healthcare staff

A follow-up on follow-up: shifting to a community-based response to improve retention in care

Heavy drinkers living with HIV have lower CD4 counts

Emergence of CXCR4-tropic HIV raises risk of AIDS fourfold

Over one year of 3TC use associated with increased risk of diabetes for HIV-positive women

Patients with undetectable viral load, but a CD4 cell count below 200 may be able to stop PCP prophylaxis

Start treatment at 500 or 350? UK cohort data show clear difference in risk of death

HIV/HCV coinfected patients who develop severe allergy to nevirapine have significantly increased risk of death